Challenges around data are mostly around data itself, particularly if it is not timely, says Lee A. Norman, MD, MHS, MBA, the senior medical director for Optum Care Kansas City.
The data used in clinical decision-making needs to be as real time as possible, said Lee A. Norman, MD, MHS, MBA, who appeared at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on population health in Kansas City, Missouri. He served as the secretary of the Kansas Department of Health and Environment from 2019 to 2021 under Governor Laura Kelly. Norman, who also served in the US Air Force and later as a colonel in the Kansas Army National Guard, is currently senior medical director for Optum Care Kansas City.
Transcript
What are some of the challenges to implementing data in health care practices improve patient care?
The challenges are mostly around data itself, which is, do we have the quality of data and is it timely? I can remember back in the olden days, let's say in the mid-80s, where we signed up to take care of patients and HMO [health management organization] plans, and we didn't have any data as the month would go along. And then all of a sudden, at the end of the year, we'd find out how we did, both in terms of clinical data and in terms of financial performance. That's not adequate. Those plans went bye-bye.
What is really necessary now is data that's almost as real time as possible and [that can] help us to understand where are we strong? Where are we weak? How does this patient fare in this value-based world compared to the fee-for-service world? There shouldn't be a whole vast difference between those worlds as it relates to patient outcomes. But it's very critical, and it always has been, but we're getting better at it, to have data at our fingertips to make good clinical decision-making.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS
June 24th 2025In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.
Read More
The High Cost of Healthy: How Grocery Prices Shape American Diets and Health
June 24th 2025Rising grocery prices are forcing most Americans to shift toward ultraprocessed foods, leading to increased health risks and exacerbating existing disparities, particularly among underserved communities.
Read More